Hertie Institute for Clinical Brain Research
Wikidata: Q30287260
Hertie Institute for Clinical Brain Research
1 Projects, page 1 of 1
assignment_turned_in ProjectFrom 2014Partners:University of Tübingen, Laboratoire NEURO-PSI - UMR 9197, Department of Experimental Medical Science, Wallenberg Neuroscience Centre, INSTITUT PASTEUR (BP), Hertie Institute for Clinical Brain ResearchUniversity of Tübingen,Laboratoire NEURO-PSI - UMR 9197,Department of Experimental Medical Science, Wallenberg Neuroscience Centre,INSTITUT PASTEUR (BP),Hertie Institute for Clinical Brain ResearchFunder: French National Research Agency (ANR) Project Code: ANR-14-JPCD-0002Funder Contribution: 556,643 EUREmerging results suggest that the trigger of a variety of neurodegenerative diseases is the formation of pathogenic protein aggregates (“seeds”), which self-propagate in a prion-like manner. Current data support the hypothesis that progression of different neurodegenerative diseases can be caused by cell-to-cell spread of such proteinaceous seeds. We aim to elucidate the key mechanisms by which proteins misfold into toxic assemblies and then transfer between neurons and along neural pathways, thus facilitating the propagation of the disease in the CNS. By studying these mechanisms using a systematic approach at multi-levels from molecules, cells, organs to animal models and combining structural and biophysical techniques, biochemistry, cell biology, and imaging, we then aim to develop novel therapeutic targets to stop the self-replication and propagation and thus disease progression. To identify common molecular pathways we will mainly cross-examine two of these diseases, Alzheimer´s disease (AD) and Parkinson´s disease (PD), and concentrate on the analysis of amyloid-beta (Aß) and alpha-synuclein (aS) aggregates.
more_vert
